SEC Form 4 · accession 0001140361-17-044957
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Eric Davis
Officer — EVP, General Counsel
Period of report
Nov 30, 2017
Accepted (ET)
Dec 4, 2017 · 8:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 30, 2017 | S | 1,200 | $85.639 | D | 82,942 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1All shares sold at the same price.
- F2Amount of securities beneficially owned has been updated from the reporting person's prior report to: a) include 804 shares reported in the Form 4 Amendment filed with the S.E.C. on 10/13/2017; and b) exclude 243 shares inadvertently included in prior reports based on a reconciliation with the Company's records.